The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for GM Coppola


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides.EBI
TBA
1-Aminomethylisoquinoline-4-carboxylates as novel dipeptidylpeptidase IV inhibitors.EBI
Novartis Institute For Biomedical Research
 
Design and biological evaluation of a series of thiophene-based 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitorsEBI
TBA
Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents.EBI
Novartis Institutes For Biomedical Research
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors.EBI
Novartis Institutes For Biomedical Research
Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase.EBI
Novartis Institute For Biomedical Research
(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase.EBI
Novartis Institute For Biomedical Research
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.EBI
Novartis Institutes For Biomedical Research
3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic useBDB
Institute of Cancer Research
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.BDB
Virginia Commonwealth University